Cepharanthine analogs mining and genomes of Stephania accelerate anti-coronavirus drug discovery
By Maochen Li, Sanyin Zhang and Zhichao Xu
‘Corona actively evolving, new mutations may affect vulnerable’
By SV Krishna Chaitanya
New tARC-seq method enhances precision in tracking SARS-CoV-2 mutations
By Pooja Toshniwal Paharia
Targeted accurate RNA consensus sequencing (tARC-seq) reveals mechanisms of replication error affecting SARS-CoV-2 divergence
By Olivier Lichtarge, Pamela N Luna and Brendan F Kohrn
How are new Covid variants generated? Hidden mechanism revealed
(PDF) Influence of variants mutations on the progression and outcome of COVID-19 in Pakistan
New RNA-Based Sequencing Approach Tracks COVID Variants
Full coverage of this story
27% dip in weekly Covid cases, present surge may have peaked
By Amit Bhattacharya
Takeaways from AP report on how the search for the coronavirus origins turned toxic
By Maria Cheng and Dake Kang
What's Next for the Coronavirus?
By Apoorva Mandavilli
Researchers say bats in UK harbor novel coronaviruses
By Stephanie Soucheray
Monitoring British bats can help identify coronaviruses with pathogen potential | Imperial News
By Hayley Dunning
A Brief History of Human Coronaviruses
By Shawna Williams
Coronavirus's Spike Proteins Have 'Hinges' That Can Be Targeted to Help Battle Infections! | Weather.com
By Ashmita Gupta
Harvard Health Publishing Q&a: Coronavirus
By Howard E Lewine
Tubeimosides are pan-coronavirus and filovirus inhibitors that can block their fusion protein binding to Niemann-Pick C1
By Gongxun Zhong, Yong-Hui Zheng and Jinliang Wang
LY6E is a pan-coronavirus restriction factor in the respiratory tract
By Katrina B Mar, Alexandra I Wells and John M Shelton
4 years after the COVID emergency, what the coronavirus means today
By Priyanka Dayal McCluskey
Symptom profiles of community cases infected by influenza, RSV, rhinovirus, seasonal coronavirus, and SARS-CoV-2 variants of concern | Scientific Reports
By Isobel Braithwaite, Andrew Hayward and Susan Hoskins
America's split on whether the pandemic is over
By Maya Goldman